Neuraxpharm And Panaxia Pioneer Medical Cannabis Extract For Vaporization In Europe
Partnering Companies Start With Germany Under Joint Brand Naxiva-Panaxol
Neuraxpharm and Panaxia have become the first companies in the world to market medical cannabis extract, under the joint brand Naxiva-Panaxol, for vaporization in Germany. Under the agreement, the extracts will be manufactured by Panaxia and marketed in Germany by Neuraxpharm.
You may also be interested in...
Neuraxpharm and Panaxia have continued to push forward with their partnership on medical cannabis, exporting sublingual tablets to France as part of a pilot program organized by local regulator ANSM.
CNS specialist Neuraxpharm has struck a deal with Israel’s Panaxia to market medical cannabis products in Europe, starting in Germany.
Kelix bio has announced two deals to expand its presence in Africa. The company is set to acquire 14 oncology injectable products from Germany-based Vitane. Furthermore, Kelix has acquired Pharmaceutical Institute, a pharmaceutical company established in Rabat, to enter Morocco. The pan-African company has also invested in Malta.